Form D · Biotechnology

BAROSENSE INC

Redwood City, CA · CIK 0001178038

Offering snapshot reported Sep 24, 2009 · SEC filing

Reported sold: $29.5M
Investors reported: 31
Minimum accepted: $0
First sale: Aug 13, 2009

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$27,414,578 → $29,485,394
Reported investors14 → 31

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 24, 2009	Amendment	$29,485,394	$2,070,816vs Aug 21, 2009	31	SEC filing
Aug 21, 2009	Initial	$27,414,578	No comparison	14	SEC filing
Jan 26, 2009	Paper	Not reported	No comparison	Not reported	SEC filing
Jan 8, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Not reported
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $285K (estimated)
Form D file number: 021-45588

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
BIO-IB Capital Partners, LLC	145134

Source: Form D, filed Sep 24, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Daniel J. Balbierz	Director, Executive
Gregory A. Barrett	Director
Alan Levy	Director
Eric Linsley	Director
John Onopchenko	Director
Richard Stack	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

3698 Haven Avenue Suite C
Redwood City, CA, 94063